Novartis Ag (NVS) Net Shares Issued and Repurchased (2009 - 2026)

Novartis Ag has disclosed Net Shares Issued and Repurchased across 9 years of filings, most recently posting -$3.1 billion for Q2 2026.

• In Q2 2026, Net Shares Issued and Repurchased rose 43.39% year-over-year to -$3.1 billion; the TTM figure through Jun 2026 stood at -$3.1 billion (up 43.39% YoY), while the FY2025 annual figure was -$5.4 billion, down 96.6% from the prior year.
• Net Shares Issued and Repurchased came in at -$3.1 billion for Q2 2026 at Novartis Ag, down from -$1.9 billion in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of -$1.1 billion in Q1 2024 to a low of -$10.7 billion in Q4 2022.
• Average Net Shares Issued and Repurchased over 5 years is -$4.0 billion, with a median of -$2.9 billion recorded in 2024.
• Year-over-year, Net Shares Issued and Repurchased surged 68.32% in 2024 and slumped 147.13% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at -$10.7 billion in 2022, then grew by 18.15% to -$8.7 billion in 2023, then surged by 68.32% to -$2.8 billion in 2024, then slumped by 96.6% to -$5.4 billion in 2025, then surged by 43.39% to -$3.1 billion in 2026.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were -$3.1 billion in Q2 2026, -$1.9 billion in Q1 2026, and -$5.4 billion in Q4 2025.